REFERENCES
- Takaori, M., Fukui, A. (1996). Treatment of massive hemorrhage with liposome encapsulated human hemoglobin (NRC) and hydroxyethyl starch (HES) in beagles. Artif. Cell Blood Subst.Immobil. Biotech. 24 (6): 643–653.
- Tsutsui, Y., Kimura, T., Ishizuka, T., Oomori, S., Shizawa, T., Goto, H., Ogata, Y., Kaneda, S. (2002). Duration of efficacy of NRC (Neo Red Cell) in arat hemodilution model. Artificial Blood 10: 36–41.
- Kobayashi, K. (2003). Evaluation of artificial oxygen carrier in vivo—History and perspective of Keio-Waseda Joint Project of oxygen infusions. Artificial Blood 11: 37.
- Center for Biologic Evaluation and Research. (1994). Points to consider in the safety evaluation of hemoglobin based oxygen carriers. Transfusion 31: 369–371. [CROSSREF]
- Center for Bilogic Evaluation and Research. (1994). Points to consider in the safety evaluation of hemoglobin-based and perfluorocarbon-based oxygen carriers. Transfusion 34: 712–713. [CSA], [CROSSREF]
- Przybelski, R.L., Daily, E.K., Stern, K.N., MattiaGoldberg, C.A. (1997). A grade scale for assessment of safety of blood substitutes. Transfusion 37: 749–751. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Fratantoni, J.C. (1998). Red Cell Substitutes: Evolution of Approaches for Demonstrating Efficacy in Blood Substitutes - Present and Future Perspectives. (ed.) Tsuchida, E. Amsterdam, Elsevier Sci., pp. 33–39.
- Schou, H., de Sa, V.P., Larsson, A. (1998) Central and mixed venous blood oxygen correlate well during acute normovolemic hemodilution in anesthetized pigs. Acta Anaesthesiol. Scand. 42: 172–177. [PUBMED], [INFOTRIEVE]
- Hiippala, S., Linko, K., Myllylae, G., Lalla, M., Hekali, R., Maekelaeinen, A. (1995). Replacement of major surgical blood loss by hypo-oncotic or conventional plasma substitutes. Acta Anaesthesiol. Scand. 39: 228–235. [PUBMED], [INFOTRIEVE]